Pharmacy Drugs
Recent Posts
- Democrats Push Medical Device Liability Bill
- FDA Investigates Heparin Link in Two Delaware Deaths
- Conflict Of Interest Reported In 29 Percent Of Cancer Studies
- Interim Results Of Abbott’s PROGRESS Study Show Rapid Viral Decline In Dual-Therapy Regimen Of Kaletra(R) (lopinavir/ritonavir) And Raltegravir
- Survival For Prostate Cancer Patients Younger Than 50 Improved By Surgery
Random Posts
- ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data At The Association For Research In Vision And Ophthalmology (ARVO) 2009 Annual Meeting
- Pfizer Offers Year of Free Meds to Unemployed
- Genetic And Chromosomal Abnormalities In Embryos Detected By New Test
- FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter
- St. Jude Medical Announces Leading Sponsorship Of Landmark Clinical Trial To Study Atrial Fibrillation
- Promising Robotic Therapy For Cerebral Palsy
- Aegerion Pharmaceuticals Announces Final Lomitapide (AEGR-733) Phase II Data
- Cataract Surgery Helps AMD Patients; Steroid Improves DME; Online Eye Health Forum
- NCPA: Patient Survey Finds Widespread Problems With Mail Order Pharmacies
- Healthcare Reform Expert And Former Senate Majority Leader Tom Daschle To Address NACDS Pharmacy & Technology Conference
FDA Approves Generic Prescription-Only Version Of Plan B Emergency Contraceptive For Women Ages 17 And Under
Posted by: admin in Pharmacy Drugs on June 29th, 2009
The U.S. fda.gov/” rel=”nofollow”>Food and Drug Administration approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.
Plan B was first approved in 1999 for prescription use only for women of all ages. Plan B is manufactured by Duramed Pharmaceuticals Inc., of Cincinnati.
In 2006, Plan B was approved for nonprescription use for women ages 18 and older. Plan B remained available as a prescription-only product for women ages 17 and under. Today’s approval allows marketing of a prescription-only generic product for women ages 17 and under. No generic levonorgestrel product for emergency contraception can be approved for nonprescription use in women ages 18 and older until Aug. 24, 2009, when the marketing exclusivity held by Duramed for the nonprescription use expires.
The generic levonorgestrel tablets 0.75 mg are made by Watson Laboratories Inc., based in Corona, Calif.
Levonorgestrel can prevent pregnancy after unprotected intercourse or a known or suspected contraceptive failure. It is not effective in terminating an existing pregnancy and does not protect against sexually transmitted diseases, including HIV infection.
Source
U.S. Food and Drug Administration
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.